Lexagene Holdings Inc V.LXG

Primary Symbol: LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > Surprised at the low volume

<< Previous

Bullboard Posts

Next >>

Comment by iamjunobazon Aug 18, 2020 5:08am

106 Views

Post# 31421393

RE:RE:RE:RE:RE:RE: Surprised at the low volume

Let me explain how a bought deal works

Company issue shares to broker for a set amount of money

eg 6 million shares issued by Lexagene at say $1 so in a bought deal Canaccord would pay Lexagene $6 million for the 6 million shares less an arrangement fee of circa 6% (nice work) $600,000. Cannacord then offer the shares to private investors through the exchange gambling on the price they can sell the whole package of 6 million shares for

Its as simple as that,Canacord just facilitate the deal and make a nice little fee doing it

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features